Skip to main content
ProGen, Co,, LTD. logo

ProGen, Co,, LTD. — Investor Relations & Filings

Ticker · 296160 ISIN · KR7296160005 KO Manufacturing
Open in API
Filings indexed 153 across all filing types
Latest filing 2021-03-31 Audit Report / Informat…
Country KR South Korea
Listing KO 296160

About ProGen, Co,, LTD.

https://progen.co.kr

ProGen is an R&D-focused biopharmaceutical company dedicated to developing innovative drugs for incurable diseases, with a primary focus on oncology, immune diseases, and metabolic disorders. The company specializes in creating novel protein-based immunotherapies and antibody therapeutics. Its research and development efforts are driven by proprietary technology platforms, including the NTIG (Neo Tri-ImmunoGlobulin) platform for next-generation multi-specific fusion proteins and the hyFc® platform for long-acting fusion proteins. These technologies enable the engineering of advanced bi-specific and multi-specific therapies designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
감사보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'ProGen' (주식회사 프로젠) for the fiscal year ending December 31, 2020. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. This is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR). FY 2020
2021-03-31 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Progen' (주식회사 프로젠) for the fiscal year 2019. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a formal, full-year financial audit document, not an earnings release or a simple announcement, fitting the definition of an Audit Report (AR). FY 2019
2020-03-31 Korean
감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Progen' (주식회사 프로젠) for the fiscal years 2017 and 2018. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes (주석) on accounting policies. This is a comprehensive financial audit document, not an annual report (10-K) which would include management discussion and analysis (MD&A) and broader business descriptions, nor is it a short announcement. Therefore, it is classified as an Audit Report. FY 2018
2019-04-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.